Angiotensin Converting Enzyme 2 News and Research

RSS
New N501Y SARS-CoV-2 mutations increase binding to host cell receptor

New N501Y SARS-CoV-2 mutations increase binding to host cell receptor

SARS-CoV-2 nucleoprotein increases infectivity of spike-based pseudoviruses

SARS-CoV-2 nucleoprotein increases infectivity of spike-based pseudoviruses

Bats and pangolins in Southeast Asia harbor SARS-CoV-2-related coronaviruses, study finds

Bats and pangolins in Southeast Asia harbor SARS-CoV-2-related coronaviruses, study finds

The origin of SARS-CoV-2 furin cleavage site remains a mystery

The origin of SARS-CoV-2 furin cleavage site remains a mystery

Probiotics may be beneficial in COVID-19 treatment

Probiotics may be beneficial in COVID-19 treatment

Detection of emerging SARS-CoV-2 variant in New York

Detection of emerging SARS-CoV-2 variant in New York

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

How SARS-CoV-2 enters the central nervous system

How SARS-CoV-2 enters the central nervous system

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

RIG-1-like receptors may play dominant role in suppressing SARS-CoV-2 infection

RIG-1-like receptors may play dominant role in suppressing SARS-CoV-2 infection

Nanobodies protect against SARS-CoV-2 variants in animal model

Nanobodies protect against SARS-CoV-2 variants in animal model

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

New mouse model of SARS-CoV-2 infection reflects features of human infection

New mouse model of SARS-CoV-2 infection reflects features of human infection

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Statins shown to reduce COVID-19 severity and lower mortality

Statins shown to reduce COVID-19 severity and lower mortality

Brain pericytes serve as a potential hub for SARS-CoV-2 infection

Brain pericytes serve as a potential hub for SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.